214 related articles for article (PubMed ID: 21283672)
1. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells.
Alimirah F; Peng X; Murillo G; Mehta RG
PLoS One; 2011 Jan; 6(1):e16024. PubMed ID: 21283672
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism.
Sharma V; Fretwell D; Crees Z; Kerege A; Klopper JP
Thyroid; 2010 Oct; 20(10):1103-11. PubMed ID: 20860424
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI.
O Neill V; Asani FF; Jeffery TJ; Saccone DS; Bornman L
PLoS One; 2013; 8(6):e67663. PubMed ID: 23805323
[TBL] [Abstract][Full Text] [Related]
4. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
6. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
8. Serum Vitamin D status and VDR (
Faiz M; Younus A; Yasmin A
J Cancer Res Ther; 2023 Apr; 19(Supplement):S87-S92. PubMed ID: 37147988
[TBL] [Abstract][Full Text] [Related]
9. VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients.
Morán-Auth Y; Penna-Martinez M; Badenhoop K
J Steroid Biochem Mol Biol; 2015 Apr; 148():184-6. PubMed ID: 25576905
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.
Gross C; Krishnan AV; Malloy PJ; Eccleshall TR; Zhao XY; Feldman D
J Bone Miner Res; 1998 Nov; 13(11):1691-9. PubMed ID: 9797477
[TBL] [Abstract][Full Text] [Related]
11. [Influence of vitamin D receptor FokI polymorphism on expression of CYP24A1 in periodontal cells].
Liu KN; Meng HX; Hou JX
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):13-19. PubMed ID: 29483716
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
13. [Association of the vitamin D receptor gene start codon polymorphism with vitamin D deficiency rickets].
Lu HJ; Li HL; Hao P; Li JM; Zhou LF
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):493-6. PubMed ID: 14746673
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer.
McCullough ML; Bostick RM; Mayo TL
Annu Rev Nutr; 2009; 29():111-32. PubMed ID: 19400699
[TBL] [Abstract][Full Text] [Related]
15. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
[TBL] [Abstract][Full Text] [Related]
17. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
[TBL] [Abstract][Full Text] [Related]
18. Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.
Alimirah F; Vaishnav A; McCormick M; Echchgadda I; Chatterjee B; Mehta RG; Peng X
Mol Cell Biochem; 2010 Sep; 342(1-2):143-50. PubMed ID: 20440542
[TBL] [Abstract][Full Text] [Related]
19. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer.
Fuhrman BJ; Freedman DM; Bhatti P; Doody MM; Fu YP; Chang SC; Linet MS; Sigurdson AJ
Anticancer Res; 2013 Feb; 33(2):543-51. PubMed ID: 23393347
[TBL] [Abstract][Full Text] [Related]
20. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
